Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

14 Jun 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial of MM-II in Patients with Painful Knee Osteoarthritis (OA), which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..